Remote ischemic conditioning in cerebral diseases and neurointerventional procedures

Recent research progress

Geng Zhou, Ming Hua Li, Gabriel Tudor, Hai Tao Lu, Ramanathan D Kadirvel, David F Kallmes

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Cerebral ischemia and stroke are increasing in prevalence and are among the leading causes of morbidity and mortality in both developed and developing countries. Despite the progress in endovascular treatment, ischemia/reperfusion (IR) injury is an important contributor to post-surgical mortality and morbidity affecting a wide range of neurointerventional procedures. However, pharmacological recruitment of effective cerebral protective signaling has been largely disappointing to date. In remote ischemic conditioning (RIC), repetitive transient mechanical obstruction of vessels at a limb remote from the IR injury site protects vital organs from IR injury and confers infarction size reduction following prolonged arterial occlusion. Results of pharmacologic agents appear to be species specific, while RIC is based on the neuroprotective influences of phosphorylated protein kinase B, signaling proteins, nitric oxide, and transcriptional activators, the benefits of which have been confirmed in many species. Inducing RIC protection in patients undergoing cerebral vascular surgery or those who are at high risk of brain injury has been the subject of research and has been enacted in clinical settings. Its simplicity and non-invasive nature, as well as the flexibility of the timing of RIC stimulus, also makes it feasible to apply alongside neurointerventional procedures. Furthermore, despite nonuniform RIC protocols, emerging literature demonstrates improved clinical outcomes. The aims of this article are to summarize the potential mechanisms underlying different forms of conditioning, to explore the current translation of this paradigm from laboratory to neurovascular diseases, and to outline applications for patient care.

Original languageEnglish (US)
Article number339
JournalFrontiers in Neurology
Volume9
Issue numberMAY
DOIs
StatePublished - May 16 2018

Fingerprint

Reperfusion Injury
Research
Morbidity
Proto-Oncogene Proteins c-akt
Mortality
Brain Ischemia
Developed Countries
Brain Injuries
Infarction
Developing Countries
Blood Vessels
Patient Care
Nitric Oxide
Extremities
Stroke
Pharmacology
Proteins
Therapeutics

Keywords

  • Acute ischemic stroke
  • Ischemia/reperfusion injury
  • Neurointerventional procedures
  • Neuroprotection
  • Remote ischemic conditioning

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Remote ischemic conditioning in cerebral diseases and neurointerventional procedures : Recent research progress. / Zhou, Geng; Li, Ming Hua; Tudor, Gabriel; Lu, Hai Tao; Kadirvel, Ramanathan D; Kallmes, David F.

In: Frontiers in Neurology, Vol. 9, No. MAY, 339, 16.05.2018.

Research output: Contribution to journalReview article

@article{fa6ff09df5544164b18b83efacf1bd99,
title = "Remote ischemic conditioning in cerebral diseases and neurointerventional procedures: Recent research progress",
abstract = "Cerebral ischemia and stroke are increasing in prevalence and are among the leading causes of morbidity and mortality in both developed and developing countries. Despite the progress in endovascular treatment, ischemia/reperfusion (IR) injury is an important contributor to post-surgical mortality and morbidity affecting a wide range of neurointerventional procedures. However, pharmacological recruitment of effective cerebral protective signaling has been largely disappointing to date. In remote ischemic conditioning (RIC), repetitive transient mechanical obstruction of vessels at a limb remote from the IR injury site protects vital organs from IR injury and confers infarction size reduction following prolonged arterial occlusion. Results of pharmacologic agents appear to be species specific, while RIC is based on the neuroprotective influences of phosphorylated protein kinase B, signaling proteins, nitric oxide, and transcriptional activators, the benefits of which have been confirmed in many species. Inducing RIC protection in patients undergoing cerebral vascular surgery or those who are at high risk of brain injury has been the subject of research and has been enacted in clinical settings. Its simplicity and non-invasive nature, as well as the flexibility of the timing of RIC stimulus, also makes it feasible to apply alongside neurointerventional procedures. Furthermore, despite nonuniform RIC protocols, emerging literature demonstrates improved clinical outcomes. The aims of this article are to summarize the potential mechanisms underlying different forms of conditioning, to explore the current translation of this paradigm from laboratory to neurovascular diseases, and to outline applications for patient care.",
keywords = "Acute ischemic stroke, Ischemia/reperfusion injury, Neurointerventional procedures, Neuroprotection, Remote ischemic conditioning",
author = "Geng Zhou and Li, {Ming Hua} and Gabriel Tudor and Lu, {Hai Tao} and Kadirvel, {Ramanathan D} and Kallmes, {David F}",
year = "2018",
month = "5",
day = "16",
doi = "10.3389/fneur.2018.00339",
language = "English (US)",
volume = "9",
journal = "Frontiers in Neurology",
issn = "1664-2295",
publisher = "Frontiers Research Foundation",
number = "MAY",

}

TY - JOUR

T1 - Remote ischemic conditioning in cerebral diseases and neurointerventional procedures

T2 - Recent research progress

AU - Zhou, Geng

AU - Li, Ming Hua

AU - Tudor, Gabriel

AU - Lu, Hai Tao

AU - Kadirvel, Ramanathan D

AU - Kallmes, David F

PY - 2018/5/16

Y1 - 2018/5/16

N2 - Cerebral ischemia and stroke are increasing in prevalence and are among the leading causes of morbidity and mortality in both developed and developing countries. Despite the progress in endovascular treatment, ischemia/reperfusion (IR) injury is an important contributor to post-surgical mortality and morbidity affecting a wide range of neurointerventional procedures. However, pharmacological recruitment of effective cerebral protective signaling has been largely disappointing to date. In remote ischemic conditioning (RIC), repetitive transient mechanical obstruction of vessels at a limb remote from the IR injury site protects vital organs from IR injury and confers infarction size reduction following prolonged arterial occlusion. Results of pharmacologic agents appear to be species specific, while RIC is based on the neuroprotective influences of phosphorylated protein kinase B, signaling proteins, nitric oxide, and transcriptional activators, the benefits of which have been confirmed in many species. Inducing RIC protection in patients undergoing cerebral vascular surgery or those who are at high risk of brain injury has been the subject of research and has been enacted in clinical settings. Its simplicity and non-invasive nature, as well as the flexibility of the timing of RIC stimulus, also makes it feasible to apply alongside neurointerventional procedures. Furthermore, despite nonuniform RIC protocols, emerging literature demonstrates improved clinical outcomes. The aims of this article are to summarize the potential mechanisms underlying different forms of conditioning, to explore the current translation of this paradigm from laboratory to neurovascular diseases, and to outline applications for patient care.

AB - Cerebral ischemia and stroke are increasing in prevalence and are among the leading causes of morbidity and mortality in both developed and developing countries. Despite the progress in endovascular treatment, ischemia/reperfusion (IR) injury is an important contributor to post-surgical mortality and morbidity affecting a wide range of neurointerventional procedures. However, pharmacological recruitment of effective cerebral protective signaling has been largely disappointing to date. In remote ischemic conditioning (RIC), repetitive transient mechanical obstruction of vessels at a limb remote from the IR injury site protects vital organs from IR injury and confers infarction size reduction following prolonged arterial occlusion. Results of pharmacologic agents appear to be species specific, while RIC is based on the neuroprotective influences of phosphorylated protein kinase B, signaling proteins, nitric oxide, and transcriptional activators, the benefits of which have been confirmed in many species. Inducing RIC protection in patients undergoing cerebral vascular surgery or those who are at high risk of brain injury has been the subject of research and has been enacted in clinical settings. Its simplicity and non-invasive nature, as well as the flexibility of the timing of RIC stimulus, also makes it feasible to apply alongside neurointerventional procedures. Furthermore, despite nonuniform RIC protocols, emerging literature demonstrates improved clinical outcomes. The aims of this article are to summarize the potential mechanisms underlying different forms of conditioning, to explore the current translation of this paradigm from laboratory to neurovascular diseases, and to outline applications for patient care.

KW - Acute ischemic stroke

KW - Ischemia/reperfusion injury

KW - Neurointerventional procedures

KW - Neuroprotection

KW - Remote ischemic conditioning

UR - http://www.scopus.com/inward/record.url?scp=85047070759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047070759&partnerID=8YFLogxK

U2 - 10.3389/fneur.2018.00339

DO - 10.3389/fneur.2018.00339

M3 - Review article

VL - 9

JO - Frontiers in Neurology

JF - Frontiers in Neurology

SN - 1664-2295

IS - MAY

M1 - 339

ER -